A detailed history of Price T Rowe Associates Inc transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 8,654,106 shares of SRRK stock, worth $380 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,654,106
Previous 8,188,127 5.69%
Holding current value
$380 Million
Previous $68.2 Million 1.63%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.63 - $9.71 $3.56 Million - $4.52 Million
465,979 Added 5.69%
8,654,106 $69.3 Million
Q2 2024

Aug 14, 2024

SELL
$7.84 - $16.79 $156,690 - $335,564
-19,986 Reduced 0.24%
8,188,127 $68.2 Million
Q1 2024

May 15, 2024

SELL
$13.2 - $17.76 $1.5 Million - $2.01 Million
-113,358 Reduced 1.36%
8,208,113 $146 Million
Q4 2023

Feb 14, 2024

BUY
$6.52 - $20.32 $7.49 Million - $23.4 Million
1,149,519 Added 16.03%
8,321,471 $156 Million
Q3 2023

Nov 14, 2023

BUY
$6.02 - $7.76 $522,830 - $673,948
86,849 Added 1.23%
7,171,952 $50.9 Million
Q2 2023

Aug 14, 2023

SELL
$5.79 - $9.11 $729,893 - $1.15 Million
-126,061 Reduced 1.75%
7,085,103 $53.4 Million
Q1 2023

May 15, 2023

BUY
$7.36 - $12.72 $1.3 Million - $2.24 Million
176,144 Added 2.5%
7,211,164 $57.7 Million
Q4 2022

Feb 14, 2023

BUY
$7.02 - $9.76 $890,683 - $1.24 Million
126,878 Added 1.84%
7,035,020 $63.7 Million
Q3 2022

Nov 14, 2022

SELL
$5.33 - $11.3 $8.14 Million - $17.3 Million
-1,528,043 Reduced 18.11%
6,908,142 $47.9 Million
Q2 2022

Aug 15, 2022

BUY
$4.66 - $13.96 $12.6 Million - $37.8 Million
2,704,442 Added 47.18%
8,436,185 $46.3 Million
Q1 2022

May 16, 2022

BUY
$11.89 - $24.68 $5.58 Million - $11.6 Million
469,142 Added 8.91%
5,731,743 $73.9 Million
Q4 2021

Feb 14, 2022

BUY
$24.14 - $35.18 $464,453 - $676,863
19,240 Added 0.37%
5,262,601 $131 Million
Q3 2021

Nov 15, 2021

BUY
$27.38 - $42.21 $11.6 Million - $17.9 Million
423,324 Added 8.78%
5,243,361 $173 Million
Q2 2021

Aug 16, 2021

BUY
$26.34 - $46.62 $11.4 Million - $20.2 Million
433,188 Added 9.87%
4,820,037 $139 Million
Q1 2021

May 17, 2021

BUY
$45.96 - $68.02 $17.9 Million - $26.6 Million
390,355 Added 9.77%
4,386,849 $222 Million
Q4 2020

Feb 16, 2021

BUY
$13.72 - $51.57 $54.8 Million - $206 Million
3,996,494 New
3,996,494 $194 Million

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.27B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.